How Treatment May Help

AFINITOR® (everolimus) Tablets

Proven Results With AFINITOR

In clinical trials, the combination of AFINITOR® (everolimus) Tablets plus exemestane was:


  • Shown to more than double the time patients live without the disease getting worse (the median progression-free survival period) compared with exemestane alone
  • Proven to help delay the growth and spread of tumors

Twice the Time Vs Hormone Therapy Alone

Slows the Growth and Spread of Tumors